PARK7 and colorectal carcinoma: Ciclopirox olamine inhibits the growth of CRC cells by inducing mitochondrial dysfunction and the accumulation of ROS by reducing the expression of PARK7 by Runt-related transcription factor 1 (RUNX1) [134].